BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30391543)

  • 1. Deficiency of the mitochondrial sulfide regulator ETHE1 disturbs cell growth, glutathione level and causes proteome alterations outside mitochondria.
    Sahebekhtiari N; Fernandez-Guerra P; Nochi Z; Carlsen J; Bross P; Palmfeldt J
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):126-135. PubMed ID: 30391543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Untargeted Metabolomics Analysis Reveals a Link between ETHE1-Mediated Disruptive Redox State and Altered Metabolic Regulation.
    Sahebekhtiari N; Nielsen CB; Johannsen M; Palmfeldt J
    J Proteome Res; 2016 May; 15(5):1630-8. PubMed ID: 27074420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethylmalonic encephalopathy ETHE1 R163W/R163Q mutations alter protein stability and redox properties of the iron centre.
    Henriques BJ; Lucas TG; Rodrigues JV; Frederiksen JH; Teixeira MS; Tiranti V; Bross P; Gomes CM
    PLoS One; 2014; 9(9):e107157. PubMed ID: 25198162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics reveals that redox regulation is disrupted in patients with ethylmalonic encephalopathy.
    Palmfeldt J; Vang S; Stenbroen V; Pavlou E; Baycheva M; Buchal G; Monavari AA; Augoustides-Savvopoulou P; Mandel H; Gregersen N
    J Proteome Res; 2011 May; 10(5):2389-96. PubMed ID: 21410200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ETHE1 and MOCS1 deficiencies: Disruption of mitochondrial bioenergetics, dynamics, redox homeostasis and endoplasmic reticulum-mitochondria crosstalk in patient fibroblasts.
    Grings M; Seminotti B; Karunanidhi A; Ghaloul-Gonzalez L; Mohsen AW; Wipf P; Palmfeldt J; Vockley J; Leipnitz G
    Sci Rep; 2019 Sep; 9(1):12651. PubMed ID: 31477743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative proteomics suggests metabolic reprogramming during ETHE1 deficiency.
    Sahebekhtiari N; Thomsen MM; Sloth JJ; Stenbroen V; Zeviani M; Gregersen N; Viscomi C; Palmfeldt J
    Proteomics; 2016 Apr; 16(7):1166-76. PubMed ID: 26867521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein polysulfidation-dependent persulfide dioxygenase activity of ethylmalonic encephalopathy protein 1.
    Jung M; Kasamatsu S; Matsunaga T; Akashi S; Ono K; Nishimura A; Morita M; Abdul Hamid H; Fujii S; Kitamura H; Sawa T; Ida T; Motohashi H; Akaike T
    Biochem Biophys Res Commun; 2016 Nov; 480(2):180-186. PubMed ID: 27742479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethylmalonic encephalopathy ETHE1 p. D165H mutation alters the mitochondrial function in human skeletal muscle proteome.
    Sathe G; Deepha S; Gayathri N; Nagappa M; Parayil Sankaran B; Taly AB; Khanna T; Pandey A; Govindaraj P
    Mitochondrion; 2021 May; 58():64-71. PubMed ID: 33639274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy.
    Tiranti V; Viscomi C; Hildebrandt T; Di Meo I; Mineri R; Tiveron C; Levitt MD; Prelle A; Fagiolari G; Rimoldi M; Zeviani M
    Nat Med; 2009 Feb; 15(2):200-5. PubMed ID: 19136963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of patient mutations in human persulfide dioxygenase (ETHE1) involved in H2S catabolism.
    Kabil O; Banerjee R
    J Biol Chem; 2012 Dec; 287(53):44561-7. PubMed ID: 23144459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial Dysfunction and Redox Homeostasis Impairment as Pathomechanisms of Brain Damage in Ethylmalonic Encephalopathy: Insights from Animal and Human Studies.
    Grings M; Wajner M; Leipnitz G
    Cell Mol Neurobiol; 2022 Apr; 42(3):565-575. PubMed ID: 33034777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sources of metabolic disturbance in ETHE1-related ethylmalonic encephalopathy.
    Barth M; Ottolenghi C; Hubert L; Chrétien D; Serre V; Gobin S; Romano S; Vassault A; Sefiani A; Ricquier D; Boddaert N; Brivet M; de Keyzer Y; Munnich A; Duran M; Rabier D; Valayannopoulos V; de Lonlay P
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S443-53. PubMed ID: 20978941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism-based inhibition of human persulfide dioxygenase by γ-glutamyl-homocysteinyl-glycine.
    Kabil O; Motl N; Strack M; Seravalli J; Metzler-Nolte N; Banerjee R
    J Biol Chem; 2018 Aug; 293(32):12429-12439. PubMed ID: 29980601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic exposure to sulfide causes accelerated degradation of cytochrome c oxidase in ethylmalonic encephalopathy.
    Di Meo I; Fagiolari G; Prelle A; Viscomi C; Zeviani M; Tiranti V
    Antioxid Redox Signal; 2011 Jul; 15(2):353-62. PubMed ID: 20812865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of human persulfide dioxygenase: structural basis of ethylmalonic encephalopathy.
    Pettinati I; Brem J; McDonough MA; Schofield CJ
    Hum Mol Genet; 2015 May; 24(9):2458-69. PubMed ID: 25596185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ETHE1 mutations are specific to ethylmalonic encephalopathy.
    Tiranti V; Briem E; Lamantea E; Mineri R; Papaleo E; De Gioia L; Forlani F; Rinaldo P; Dickson P; Abu-Libdeh B; Cindro-Heberle L; Owaidha M; Jack RM; Christensen E; Burlina A; Zeviani M
    J Med Genet; 2006 Apr; 43(4):340-6. PubMed ID: 16183799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteome adaptations in Ethe1-deficient mice indicate a role in lipid catabolism and cytoskeleton organization via post-translational protein modifications.
    Hildebrandt TM; Di Meo I; Zeviani M; Viscomi C; Braun HP
    Biosci Rep; 2013 Jul; 33(4):. PubMed ID: 23800285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An atypically mild case of ethylmalonic encephalopathy with pathogenic ETHE1 variant.
    Kashima DT; Sloan-Heggen CM; Gottlieb-Smith RJ; Barone Pritchard A
    Am J Med Genet A; 2023 Jun; 191(6):1614-1618. PubMed ID: 36891747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel homozygous nonsense variant in a Chinese patient with ethylmalonic encephalopathy and a genotype-phenotype spectrum review.
    Tao Y; Han D; Li X; Wang L; Yue L; Huang C; Lu D; Li X
    Clin Chim Acta; 2020 Oct; 509():8-17. PubMed ID: 32485156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethylmalonic Encephalopathy 1 Protein Is Increased in Colorectal Adenocarcinoma.
    Ozluk E; Coppola D; Mohammad IZ; Islam T; Ghali G; Kevil CG; Shackelford RE
    Anticancer Res; 2021 Oct; 41(10):4719-4723. PubMed ID: 34593420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.